-
Meet The Company Developing Advanved Blood Tests To Detect Cancer And Other Diseases
Thursday, August 11, 2022 - 8:51am | 114Read More...Gerald Commisiong, CEO of Todos Medical Ltd. (OTCQB: TOMDF), was a guest speaker at Benzinga’s All Access on August 5th, 2022. Todos Medical is a leading in vitro diagnostics company developing of novel blood tests for the early detection of cancer and other diseases. Watch the full...
-
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength including 5 Day Dosing, 30 Day Dosing And 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim
Monday, May 2, 2022 - 10:45am | 1428Read More...5-day and 30-day dosing regimen for 60-pill bottle allows for both support (5-day dosing) to reduce 3CL protease levels and to maintain (30-day dosing) low 3CL protease levels New York, NY, and Tel Aviv, ISRAEL – May 2, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...
-
Todos Medical Initiates IRB-Waived Tollovid® Market Research Study And Announces 50% Price Reduction Until May 30th, 2022
Wednesday, April 27, 2022 - 10:58am | 1933Read More...New York, NY, and Tel Aviv, ISRAEL – April 27, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. has received an Institutional Review Board (IRB) waiver to initiate...
-
Todos Medical To Present At The Emerging Growth Conference
Monday, April 25, 2022 - 10:54am | 1084Read More...- Wednesday, April 27, 2022 at 10:00am – 10:45am EST - New York, NY, and Tel Aviv, ISRAEL – April 25, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical President and CEO Gerald Commissiong...
-
Todos Medical Appoints Philippe Goix As Chief Commercial Officer For Provista Diagnostics
Thursday, April 21, 2022 - 9:37am | 1623Read More...Strengthens Management Team and Positions the Company for Growth and Expansion New York, NY, and Tel Aviv, ISRAEL – April 21, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced the appointment of Philippe Goix as Chief...
-
Todos Medical Reports 2nd Long COVID Case Study And Launches Website For Physicians And Pediatricians To Indicate Interest In Participating In Tollovid® Long COVID Clinical Study
Wednesday, April 20, 2022 - 8:21am | 2347Read More...New York, NY, and Tel Aviv, ISRAEL – April 20, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. is reporting a case study from Dr. Lee Morgentaler of a patient who...
-
Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid® by LGC Group
Wednesday, April 20, 2022 - 7:56am | 1671Read More...New York, NY, and Tel Aviv, ISRAEL – April 19, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group’s Informed Sport certification for Tollovid...
-
New Study Reportedly Calls Into Question Merck's Ivermectin COVID Off Label Use And May Bolster 3CL Protease Inhibitors Such As Tollovid
Tuesday, April 12, 2022 - 8:23am | 963Read More...This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Even though Merck (NYSE: MRK) released information about Ivermectin use in COVID-19, the New England Journal of Medicine published another study on the use...
-
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate Of Free Sale With Daily And Acute Dosing On The Label
Wednesday, April 6, 2022 - 8:51am | 1906Read More...New York, NY, and Tel Aviv, ISRAEL – April 6, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. applauds the Biden Administration’s Acceleration of Whole-...
-
Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants
Monday, April 4, 2022 - 10:08am | 1444Read More...New York, NY, and Tel Aviv, ISRAEL – April 4, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. announced that its mechanism-based 3CL protease inhibitors Tollovir...
-
UPDATE: Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates
Monday, April 4, 2022 - 9:05am | 4684Read More...New York, NY, and Tel Aviv, ISRAEL – April 1, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and provided corporate updates. “2021...
-
Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates
Friday, April 1, 2022 - 11:38am | 4692Read More...New York, NY, and Tel Aviv, ISRAEL – April 1, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and provided corporate updates. “2021...
-
Todos Medical Reports Case Study Of Patient With Long COVID
Thursday, March 31, 2022 - 12:58pm | 1498Read More...New York, NY, and Tel Aviv, ISRAEL, March 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. is reporting a case study...
-
Billy Blanks® Endorses Todos Medical's Line Of Tollovid® Products
Monday, March 28, 2022 - 8:58am | 2379Read More...New York, NY, and Tel Aviv, ISRAEL – March 27, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced it has signed Billy Blanks®, an American fitness icon, martial artist, actor, and the creator of the Tae Bo...
-
Todos Medical To Present At The Proactive One2One Virtual Forum
Thursday, March 17, 2022 - 9:13am | 967Read More...- Thursday, March 17, 2022 at 2:00PM – 2:30PM ET - New York, NY, and Tel Aviv, ISRAEL – March 17, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical President CEO Gerald Commissiong will...
